Basil Rigas - Publications

Affiliations: 
Chemistry Stony Brook University, Stony Brook, NY, United States 
Area:
Polymer Chemistry, Pharmaceutical Chemistry
Website:
https://medicine.stonybrookmedicine.edu/medicine/cancer_prevention/rigas_lab_people/rigas

179 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Luo D, DiGiovanni MG, Wei R, LaComb JF, Williams JL, Rigas B, Mackenzie GG. Phospho-valproic acid (MDC-1112) reduces pancreatic cancer growth in patient-derived tumor xenografts and KPC mice: enhanced efficacy when combined with gemcitabine. Carcinogenesis. PMID 31584613 DOI: 10.1093/carcin/bgz170  0.48
2019 Luo D, Fraga-Lauhirat M, Millings J, Ho C, Villarreal EM, Fletchinger TC, Bonfiglio JV, Mata L, Nemesure MD, Bartels LE, Wang R, Rigas B, Mackenzie GG. Phospho-valproic acid (MDC-1112) suppresses glioblastoma growth in preclinical models through the inhibition of STAT3 phosphorylation. Carcinogenesis. PMID 30994173 DOI: 10.1093/carcin/bgz069  0.48
2018 Mattheolabakis G, Wang R, Rigas B, Mackenzie GG. [Corrigendum] Phospho‑valproic acid inhibits pancreatic cancer growth in mice: Enhanced efficacy by its formulation in poly‑(L)‑lactic acid‑poly(ethylene glycol) nanoparticles. International Journal of Oncology. PMID 30320367 DOI: 10.3892/ijo.2018.4584  0.48
2017 Mattheolabakis G, Wang R, Rigas B, Mackenzie GG. Phospho-valproic acid inhibits pancreatic cancer growth in mice: enhanced efficacy by its formulation in poly-(L)-lactic acid-poly(ethylene glycol) nanoparticles. International Journal of Oncology. PMID 28849098 DOI: 10.3892/ijo.2017.4103  0.48
2016 Mattheolabakis G, Papayannis I, Yang J, Vaeth BM, Wang R, Bandovic J, Ouyang N, Rigas B, Mackenzie GG. Phospho-aspirin (MDC-22) prevents pancreatic carcinogenesis in mice. Cancer Prevention Research (Philadelphia, Pa.). PMID 27138793 DOI: 10.1158/1940-6207.CAPR-15-0344  0.48
2016 Bartels LE, Mattheolabakis G, Vaeth BM, LaComb JF, Wang R, Zhi J, Komninou D, Rigas B, Mackenzie GG. The novel agent phospho-glycerol-ibuprofen-amide (MDC-330) inhibits glioblastoma growth in mice: an effect mediated by cyclin D1. Carcinogenesis. PMID 26905586 DOI: 10.1093/carcin/bgw017  0.48
2015 Son JS, Khair S, Pettet DW, Ouyang N, Tian X, Zhang Y, Zhu W, Mackenzie GG, Robertson CE, Ir D, Frank DN, Rigas B, Li E. Altered Interactions between the Gut Microbiome and Colonic Mucosa Precede Polyposis in APCMin/+ Mice. Plos One. 10: e0127985. PMID 26121046 DOI: 10.1371/journal.pone.0127985  0.48
2015 Rigas B, Tsioulias GJ. The evolving role of nonsteroidal anti-inflammatory drugs in colon cancer prevention: a cause for optimism. The Journal of Pharmacology and Experimental Therapeutics. 353: 2-8. PMID 25589413 DOI: 10.1124/jpet.114.220806  0.48
2015 Pulkoski-Gross A, Li J, Zheng C, Li Y, Ouyang N, Rigas B, Zucker S, Cao J. Repurposing the antipsychotic trifluoperazine as an antimetastasis agent. Molecular Pharmacology. 87: 501-12. PMID 25552486 DOI: 10.1124/mol.114.096941  0.48
2015 Wong CC, Cheng KW, Papayannis I, Mattheolabakis G, Huang L, Xie G, Ouyang N, Rigas B. Phospho-NSAIDs have enhanced efficacy in mice lacking plasma carboxylesterase: implications for their clinical pharmacology. Pharmaceutical Research. 32: 1663-75. PMID 25392229 DOI: 10.1007/s11095-014-1565-2  0.48
2014 Huang L, Wong CC, Cheng KW, Rigas B. Phospho-aspirin-2 (MDC-22) inhibits estrogen receptor positive breast cancer growth both in vitro and in vivo by a redox-dependent effect. Plos One. 9: e111720. PMID 25369051 DOI: 10.1371/journal.pone.0111720  0.48
2014 Cheng KW, Nie T, Ouyang N, Alston N, Wong CC, Mattheolabakis G, Papayannis I, Huang L, Rigas B. A novel ibuprofen derivative with anti-lung cancer properties: synthesis, formulation, pharmacokinetic and efficacy studies. International Journal of Pharmaceutics. 477: 236-43. PMID 25311177 DOI: 10.1016/j.ijpharm.2014.10.019  0.48
2014 Mattheolabakis G, Wong CC, Sun Y, Amella CA, Richards R, Constantinides PP, Rigas B. Pegylation improves the pharmacokinetics and bioavailability of small-molecule drugs hydrolyzable by esterases: a study of phospho-Ibuprofen. The Journal of Pharmacology and Experimental Therapeutics. 351: 61-6. PMID 25047517 DOI: 10.1124/jpet.114.217208  0.48
2014 Xie G, Cheng KW, Huang L, Rigas B. The in vitro metabolism of phospho-sulindac amide, a novel potential anticancer agent. Biochemical Pharmacology. 91: 249-55. PMID 25044307 DOI: 10.1016/j.bcp.2014.07.007  0.48
2014 Huang L, Wong CC, Mackenzie GG, Sun Y, Cheng KW, Vrankova K, Alston N, Ouyang N, Rigas B. Phospho-aspirin (MDC-22) inhibits breast cancer in preclinical animal models: an effect mediated by EGFR inhibition, p53 acetylation and oxidative stress. Bmc Cancer. 14: 141. PMID 24575839 DOI: 10.1186/1471-2407-14-141  0.48
2014 Murray OT, Wong CC, Vrankova K, Rigas B. Phospho-sulindac inhibits pancreatic cancer growth: NFATc1 as a drug resistance candidate. International Journal of Oncology. 44: 521-9. PMID 24284479 DOI: 10.3892/ijo.2013.2190  0.48
2013 Mackenzie GG, Bartels LE, Xie G, Papayannis I, Alston N, Vrankova K, Ouyang N, Rigas B. A novel Ras inhibitor (MDC-1016) reduces human pancreatic tumor growth in mice. Neoplasia (New York, N.Y.). 15: 1184-95. PMID 24204197 DOI: 10.1593/neo.131368  0.48
2013 Cheng KW, Wong CC, Mattheolabakis G, Xie G, Huang L, Rigas B. Curcumin enhances the lung cancer chemopreventive efficacy of phospho-sulindac by improving its pharmacokinetics. International Journal of Oncology. 43: 895-902. PMID 23807084 DOI: 10.3892/ijo.2013.1995  0.48
2013 Mackenzie GG, Huang L, Alston N, Ouyang N, Vrankova K, Mattheolabakis G, Constantinides PP, Rigas B. Targeting mitochondrial STAT3 with the novel phospho-valproic acid (MDC-1112) inhibits pancreatic cancer growth in mice. Plos One. 8: e61532. PMID 23650499 DOI: 10.1371/journal.pone.0061532  0.48
2013 Cheng KW, Wong CC, Alston N, Mackenzie GG, Huang L, Ouyang N, Xie G, Wiedmann T, Rigas B. Aerosol administration of phospho-sulindac inhibits lung tumorigenesis. Molecular Cancer Therapeutics. 12: 1417-28. PMID 23645590 DOI: 10.1158/1535-7163.MCT-13-0006-T  0.48
2013 Mattheolabakis G, Mackenzie GG, Huang L, Ouyang N, Cheng KW, Rigas B. Topically applied phospho-sulindac hydrogel is efficacious and safe in the treatment of experimental arthritis in rats. Pharmaceutical Research. 30: 1471-82. PMID 23483440 DOI: 10.1007/s11095-012-0953-8  0.48
2013 Xie G, Zhou D, Cheng KW, Wong CC, Rigas B. Comparative in vitro metabolism of phospho-tyrosol-indomethacin by mice, rats and humans. Biochemical Pharmacology. 85: 1195-202. PMID 23399640 DOI: 10.1016/j.bcp.2013.01.031  0.48
2013 Zhou D, Papayannis I, Mackenzie GG, Alston N, Ouyang N, Huang L, Nie T, Wong CC, Rigas B. The anticancer effect of phospho-tyrosol-indomethacin (MPI-621), a novel phosphoderivative of indomethacin: in vitro and in vivo studies. Carcinogenesis. 34: 943-51. PMID 23338686 DOI: 10.1093/carcin/bgs394  0.48
2013 Mironava T, Simon M, Rafailovich MH, Rigas B. Platinum folate nanoparticles toxicity: cancer vs. normal cells. Toxicology in Vitro : An International Journal Published in Association With Bibra. 27: 882-9. PMID 23318730 DOI: 10.1016/j.tiv.2013.01.005  0.48
2012 Mattheolabakis G, Rigas B, Constantinides PP. Nanodelivery strategies in cancer chemotherapy: biological rationale and pharmaceutical perspectives. Nanomedicine (London, England). 7: 1577-90. PMID 23148540 DOI: 10.2217/nnm.12.128  0.48
2012 Cohenford MA, Lim S, Brown C, Chaudhry MA, Sigdel S, Beckelhimer E, Rigas B. FT-IR microspectroscopy of mouse colon tissues: insight into the chemistry of carcinogenesis and diagnostic potential. The American Journal of Pathology. 181: 1961-8. PMID 23063512 DOI: 10.1016/j.ajpath.2012.08.039  0.48
2012 Ouyang N, Zhu C, Zhou D, Nie T, Go MF, Richards RJ, Rigas B. MC-12, an annexin A1-based peptide, is effective in the treatment of experimental colitis. Plos One. 7: e41585. PMID 22844504 DOI: 10.1371/journal.pone.0041585  0.48
2012 Cheng KW, Mattheolabakis G, Wong CC, Ouyang N, Huang L, Constantinides PP, Rigas B. Topical phospho-sulindac (OXT-328) is effective in the treatment of non-melanoma skin cancer. International Journal of Oncology. 41: 1199-203. PMID 22842609 DOI: 10.3892/ijo.2012.1577  0.48
2012 Xie G, Wong CC, Cheng KW, Huang L, Constantinides PP, Rigas B. In vitro and in vivo metabolic studies of phospho-aspirin (MDC-22). Pharmaceutical Research. 29: 3292-301. PMID 22782648 DOI: 10.1007/s11095-012-0821-6  0.48
2012 Zhu R, Cheng KW, Mackenzie G, Huang L, Sun Y, Xie G, Vrankova K, Constantinides PP, Rigas B. Phospho-sulindac (OXT-328) inhibits the growth of human lung cancer xenografts in mice: enhanced efficacy and mitochondria targeting by its formulation in solid lipid nanoparticles. Pharmaceutical Research. 29: 3090-101. PMID 22723123 DOI: 10.1007/s11095-012-0801-x  0.48
2012 Zhu C, Cheng KW, Ouyang N, Huang L, Sun Y, Constantinides P, Rigas B. Phosphosulindac (OXT-328) selectively targets breast cancer stem cells in vitro and in human breast cancer xenografts. Stem Cells (Dayton, Ohio). 30: 2065-75. PMID 22653497 DOI: 10.1002/stem.1139  0.48
2012 Xie G, Wong CC, Cheng KW, Huang L, Constantinides PP, Rigas B. Regioselective oxidation of phospho-NSAIDs by human cytochrome P450 and flavin monooxygenase isoforms: implications for their pharmacokinetic properties and safety. British Journal of Pharmacology. 167: 222-32. PMID 22489789 DOI: 10.1111/j.1476-5381.2012.01982.x  0.48
2012 Wong CC, Cheng KW, Rigas B. Preclinical predictors of anticancer drug efficacy: critical assessment with emphasis on whether nanomolar potency should be required of candidate agents. The Journal of Pharmacology and Experimental Therapeutics. 341: 572-8. PMID 22448039 DOI: 10.1124/jpet.112.191957  0.48
2012 Sun Y, Rowehl LM, Huang L, Mackenzie GG, Vrankova K, Komninou D, Rigas B. Phospho-ibuprofen (MDC-917) suppresses breast cancer growth: an effect controlled by the thioredoxin system. Breast Cancer Research : Bcr. 14: R20. PMID 22293394 DOI: 10.1186/bcr3105  0.48
2012 Nie T, Wong CC, Alston N, Aro P, Constantinides PP, Rigas B. Phospho-ibuprofen (MDC-917) incorporated in nanocarriers: anti-cancer activity in vitro and in vivo. British Journal of Pharmacology. 166: 991-1001. PMID 22141583 DOI: 10.1111/j.1476-5381.2011.01799.x  0.48
2012 Wong CC, Cheng KW, Xie G, Zhou D, Zhu CH, Constantinides PP, Rigas B. Carboxylesterases 1 and 2 hydrolyze phospho-nonsteroidal anti-inflammatory drugs: relevance to their pharmacological activity. The Journal of Pharmacology and Experimental Therapeutics. 340: 422-32. PMID 22085648 DOI: 10.1124/jpet.111.188508  0.48
2012 Mattheolabakis G, Nie T, Constantinides PP, Rigas B. Sterically stabilized liposomes incorporating the novel anticancer agent phospho-ibuprofen (MDC-917): preparation, characterization, and in vitro/in vivo evaluation. Pharmaceutical Research. 29: 1435-43. PMID 22072052 DOI: 10.1007/s11095-011-0619-y  0.48
2012 Xie G, Nie T, Mackenzie GG, Sun Y, Huang L, Ouyang N, Alston N, Zhu C, Murray OT, Constantinides PP, Kopelovich L, Rigas B. The metabolism and pharmacokinetics of phospho-sulindac (OXT-328) and the effect of difluoromethylornithine. British Journal of Pharmacology. 165: 2152-66. PMID 21955327 DOI: 10.1111/j.1476-5381.2011.01705.x  0.48
2012 Williams JL, Ji P, Ouyang N, Kopelovich L, Rigas B. Corrigendum to "Protein nitration and nitrosylation by NO-donating aspirin in colon cancer cells: Relevance to its mechanism of action" [Exp Cell Res 314 (2011) 1359-1367] Experimental Cell Research. 318: 1185. DOI: 10.1016/j.yexcr.2012.04.001  0.48
2011 Huang L, Mackenzie GG, Sun Y, Ouyang N, Xie G, Vrankova K, Komninou D, Rigas B. Chemotherapeutic properties of phospho-nonsteroidal anti-inflammatory drugs, a new class of anticancer compounds. Cancer Research. 71: 7617-27. PMID 22025561 DOI: 10.1158/0008-5472.CAN-11-2349  0.48
2011 Joseph S, Nie T, Huang L, Zhou H, Atmakur K, Gupta RC, Johnson F, Rigas B. Structure-activity relationship study of novel anticancer aspirin-based compounds. Molecular Medicine Reports. 4: 891-9. PMID 21805049 DOI: 10.3892/mmr.2011.534  0.48
2011 Sun Y, Huang L, Mackenzie GG, Rigas B. Oxidative stress mediates through apoptosis the anticancer effect of phospho-nonsteroidal anti-inflammatory drugs: implications for the role of oxidative stress in the action of anticancer agents. The Journal of Pharmacology and Experimental Therapeutics. 338: 775-83. PMID 21646387 DOI: 10.1124/jpet.111.183533  0.48
2011 Mackenzie GG, Ouyang N, Xie G, Vrankova K, Huang L, Sun Y, Komninou D, Kopelovich L, Rigas B. Phospho-sulindac (OXT-328) combined with difluoromethylornithine prevents colon cancer in mice. Cancer Prevention Research (Philadelphia, Pa.). 4: 1052-60. PMID 21464038 DOI: 10.1158/1940-6207.CAPR-11-0067  0.48
2011 Xie G, Sun Y, Nie T, Mackenzie GG, Huang L, Kopelovich L, Komninou D, Rigas B. Phospho-ibuprofen (MDC-917) is a novel agent against colon cancer: efficacy, metabolism, and pharmacokinetics in mouse models. The Journal of Pharmacology and Experimental Therapeutics. 337: 876-86. PMID 21422165 DOI: 10.1124/jpet.111.180224  0.48
2011 Williams JL, Ji P, Ouyang N, Kopelovich L, Rigas B. Protein nitration and nitrosylation by NO-donating aspirin in colon cancer cells: Relevance to its mechanism of action. Experimental Cell Research. 317: 1359-67. PMID 21406194 DOI: 10.1016/j.yexcr.2011.03.001  0.48
2011 Huang L, Mackenzie G, Ouyang N, Sun Y, Xie G, Johnson F, Komninou D, Rigas B. The novel phospho-non-steroidal anti-inflammatory drugs, OXT-328, MDC-22 and MDC-917, inhibit adjuvant-induced arthritis in rats. British Journal of Pharmacology. 162: 1521-33. PMID 21175575 DOI: 10.1111/j.1476-5381.2010.01162.x  0.48
2010 Huang L, Zhu C, Sun Y, Xie G, Mackenzie GG, Qiao G, Komninou D, Rigas B. Phospho-sulindac (OXT-922) inhibits the growth of human colon cancer cell lines: a redox/polyamine-dependent effect. Carcinogenesis. 31: 1982-90. PMID 20627873 DOI: 10.1093/carcin/bgq149  0.48
2010 Mackenzie GG, Sun Y, Huang L, Xie G, Ouyang N, Gupta RC, Johnson F, Komninou D, Kopelovich L, Rigas B. Phospho-sulindac (OXT-328), a novel sulindac derivative, is safe and effective in colon cancer prevention in mice. Gastroenterology. 139: 1320-32. PMID 20600034 DOI: 10.1053/j.gastro.2010.06.044  0.48
2010 Zhang Z, Huang L, Zhao W, Rigas B. Annexin 1 induced by anti-inflammatory drugs binds to NF-kappaB and inhibits its activation: anticancer effects in vitro and in vivo. Cancer Research. 70: 2379-88. PMID 20215502 DOI: 10.1158/0008-5472.CAN-09-4204  0.48
2010 Wang Y, Zhang Z, Jain V, Yi J, Mueller S, Sokolov J, Liu Z, Levon K, Rigas B, Rafailovich MH. Potentiometric sensors based on surface molecular imprinting: Detection of cancer biomarkers and viruses Sensors and Actuators, B: Chemical. 146: 381-387. DOI: 10.1016/j.snb.2010.02.032  0.48
2009 Hua A, Mackenzie GG, Rigas B. The differential cell signaling effects of two positional isomers of the anticancer NO-donating aspirin. International Journal of Oncology. 35: 837-44. PMID 19724920 DOI: 10.3892/ijo-00000397  0.48
2009 Foreman JE, Sorg JM, McGinnis KS, Rigas B, Williams JL, Clapper ML, Gonzalez FJ, Peters JM. Regulation of peroxisome proliferator-activated receptor-beta/delta by the APC/beta-CATENIN pathway and nonsteroidal antiinflammatory drugs. Molecular Carcinogenesis. 48: 942-52. PMID 19415698 DOI: 10.1002/mc.20546  0.48
2009 Zhao W, Mackenzie GG, Murray OT, Zhang Z, Rigas B. Phosphoaspirin (MDC-43), a novel benzyl ester of aspirin, inhibits the growth of human cancer cell lines more potently than aspirin: a redox-dependent effect. Carcinogenesis. 30: 512-9. PMID 19136474 DOI: 10.1093/carcin/bgp015  0.48
2009 Sun Y, Chen J, Rigas B. Chemopreventive agents induce oxidative stress in cancer cells leading to COX-2 overexpression and COX-2-independent cell death. Carcinogenesis. 30: 93-100. PMID 18952595 DOI: 10.1093/carcin/bgn242  0.48
2009 Zhou H, Huang L, Sun Y, Rigas B. Nitric oxide-donating aspirin inhibits the growth of pancreatic cancer cells through redox-dependent signaling. Cancer Letters. 273: 292-9. PMID 18805632 DOI: 10.1016/j.canlet.2008.08.006  0.48
2008 Rigas B, Rao CV, Cooney R, Singh S. Food components, alternative medicine, and cancer: progress and promise. Nutrition and Cancer. 60: 1. PMID 19003574 DOI: 10.1080/01635580802393134  0.48
2008 Sun Y, Rigas B. The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agents. Cancer Research. 68: 8269-77. PMID 18922898 DOI: 10.1158/0008-5472.CAN-08-2010  0.48
2008 Yang K, Kurihara N, Fan K, Newmark H, Rigas B, Bancroft L, Corner G, Livote E, Lesser M, Edelmann W, Velcich A, Lipkin M, Augenlicht L. Dietary induction of colonic tumors in a mouse model of sporadic colon cancer. Cancer Research. 68: 7803-10. PMID 18829535 DOI: 10.1158/0008-5472.CAN-08-1209  0.48
2008 Rao CV, Joseph S, Gao L, Patlolla JM, Choi CI, Kopelovich L, Steele VE, Rigas B. Pharmacokinetic and pharmacodynamic study of NO-donating aspirin in F344 rats. International Journal of Oncology. 33: 799-805. PMID 18813794 DOI: 10.3892/ijo_00000067  0.48
2008 Ouyang N, Williams JL, Rigas B. NO-donating aspirin inhibits angiogenesis by suppressing VEGF expression in HT-29 human colon cancer mouse xenografts. Carcinogenesis. 29: 1794-8. PMID 18544566 DOI: 10.1093/carcin/bgn127  0.48
2008 Mackenzie GG, Rasheed S, Wertheim W, Rigas B. NO-Donating NSAIDs, PPARdelta, and Cancer: Does PPARdelta Contribute to Colon Carcinogenesis? Ppar Research. 2008: 919572. PMID 18528523 DOI: 10.1155/2008/919572  0.48
2008 Wang Y, Zhou Y, Sokolov J, Rigas B, Levon K, Rafailovich M. A potentiometric protein sensor built with surface molecular imprinting method. Biosensors & Bioelectronics. 24: 162-6. PMID 18514502 DOI: 10.1016/j.bios.2008.04.010  0.48
2008 Rasheed S, Rigas B. Screening for colorectal cancer: does it all start with aberrant crypt foci? Gastrointestinal Endoscopy. 67: 1103-5. PMID 18513552 DOI: 10.1016/j.gie.2007.10.038  0.48
2008 Rigas B, Williams JL. NO-donating NSAIDs and cancer: an overview with a note on whether NO is required for their action. Nitric Oxide : Biology and Chemistry / Official Journal of the Nitric Oxide Society. 19: 199-204. PMID 18486630 DOI: 10.1016/j.niox.2008.04.022  0.48
2008 Rigas B, Sun Y. Induction of oxidative stress as a mechanism of action of chemopreventive agents against cancer British Journal of Cancer. 98: 1157-1160. PMID 18253125 DOI: 10.1038/sj.bjc.6604225  0.48
2008 Williams JL, Ji P, Ouyang N, Liu X, Rigas B. NO-donating aspirin inhibits the activation of NF-kappaB in human cancer cell lines and Min mice. Carcinogenesis. 29: 390-7. PMID 18174252 DOI: 10.1093/carcin/bgm275  0.48
2008 Rigas B, Kozoni V. The novel phenylester anticancer compounds: Study of a derivative of aspirin (phoshoaspirin). International Journal of Oncology. 32: 97-100. PMID 18097547  0.48
2008 Jiang J, Li C, Lombardi J, Colby RH, Rigas B, Rafailovich MH, Sokolov JC. The effect of physiologically relevant additives on the rheological properties of concentrated Pluronic copolymer gels Polymer. 49: 3561-3567. DOI: 10.1016/j.polymer.2008.05.038  0.48
2007 McIlhatton MA, Tyler J, Burkholder S, Ruschoff J, Rigas B, Kopelovich L, Fishel R. Nitric oxide-donating aspirin derivatives suppress microsatellite instability in mismatch repair-deficient and hereditary nonpolyposis colorectal cancer cells. Cancer Research. 67: 10966-75. PMID 18006842 DOI: 10.1158/0008-5472.CAN-07-2562  0.48
2007 Rigas B. Novel agents for cancer prevention based on nitric oxide Biochemical Society Transactions. 35: 1364-1368. PMID 17956352 DOI: 10.1042/BST0351364  0.48
2007 Yang K, Lipkin M, Newmark H, Rigas B, Daroqui C, Maier S, Augenlicht L. Molecular targets of calcium and vitamin D in mouse genetic models of intestinal cancer. Nutrition Reviews. 65: S134-7. PMID 17867391 DOI: 10.1111/j.1753-4887.2007.tb00342.x  0.48
2007 Kozoni V, Rosenberg T, Rigas B. Development of novel agents based on nitric oxide for the control of colon cancer. Acta Pharmacologica Sinica. 28: 1429-33. PMID 17723176 DOI: 10.1111/j.1745-7254.2007.00696.x  0.48
2007 Kashfi K, Rigas B. The mechanism of action of nitric oxide-donating aspirin. Biochemical and Biophysical Research Communications. 358: 1096-101. PMID 17512900 DOI: 10.1016/j.bbrc.2007.05.038  0.48
2007 Rigas B. The use of nitric oxide-donating nonsteroidal anti-inflammatory drugs in the chemoprevention of colorectal neoplasia. Current Opinion in Gastroenterology. 23: 55-9. PMID 17133086 DOI: 10.1097/MOG.0b013e32801145b0  0.48
2007 Wang Y, Zhang Z, Jain V, Yi J, Mueller S, Sokolov J, Levon K, Rigas B, Rafailovich M. High sensitivity detection of biomolecules using surface molecular imprinting technology 7th World Congress: Enabling Technologies and New Markets, Nanocomposites 2007 0.48
2006 Rao CV, Reddy BS, Steele VE, Wang CX, Liu X, Ouyang N, Patlolla JM, Simi B, Kopelovich L, Rigas B. Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets. Molecular Cancer Therapeutics. 5: 1530-8. PMID 16818512 DOI: 10.1158/1535-7163.MCT-06-0061  0.48
2006 Zhang Z, Rigas B. NF-kappaB, inflammation and pancreatic carcinogenesis: NF-kappaB as a chemoprevention target (review). International Journal of Oncology. 29: 185-92. PMID 16773199  0.48
2006 Iconomou G, Kalofonos HP, Koutras AK, Vagenakis AG, Rigas B. Pilot study of nitric oxide-donating aspirin in patients with pancreatic cancer pain. The Journal of Supportive Oncology. 4: 168. PMID 16669458  0.48
2006 Ouyang N, Williams JL, Tsioulias GJ, Gao J, Iatropoulos MJ, Kopelovich L, Kashfi K, Rigas B. Nitric oxide-donating aspirin prevents pancreatic cancer in a hamster tumor model. Cancer Research. 66: 4503-11. PMID 16618778 DOI: 10.1158/0008-5472.CAN-05-3118  0.48
2006 Gao J, Kashfi K, Liu X, Rigas B. NO-donating aspirin induces phase II enzymes in vitro and in vivo. Carcinogenesis. 27: 803-10. PMID 16267095 DOI: 10.1093/carcin/bgi262  0.48
2006 Hundley TR, Rigas B. Nitric oxide-donating aspirin inhibits colon cancer cell growth via mitogen-activated protein kinase activation. The Journal of Pharmacology and Experimental Therapeutics. 316: 25-34. PMID 16169935 DOI: 10.1124/jpet.105.091363  0.48
2006 Ouyang N, Williams JL, Rigas B. NO-donating aspirin isomers downregulate peroxisome proliferator-activated receptor (PPAR)delta expression in APC(min/+) mice proportionally to their tumor inhibitory effect: Implications for the role of PPARdelta in carcinogenesis. Carcinogenesis. 27: 232-9. PMID 16141240 DOI: 10.1093/carcin/bgi221  0.48
2005 Muscat JE, Dyer AM, Rosenbaum RE, Rigas B. Nitric oxide-releasing medications and colorectal cancer risk: the framingham study. Anticancer Research. 25: 4471-4. PMID 16334128  0.48
2005 Gao J, Liu X, Rigas B. Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stress. Proceedings of the National Academy of Sciences of the United States of America. 102: 17207-12. PMID 16282376 DOI: 10.1073/pnas.0506893102  0.48
2005 Spiegel A, Hundley TR, Chen J, Gao J, Ouyang N, Liu X, Go MF, Tsioulias GJ, Kashfi K, Rigas B. NO-donating aspirin inhibits both the expression and catalytic activity of inducible nitric oxide synthase in HT-29 human colon cancer cells. Biochemical Pharmacology. 70: 993-1000. PMID 16105666 DOI: 10.1016/j.bcp.2005.06.027  0.48
2005 Kashfi K, Rigas B. Is COX-2 a 'collateral' target in cancer prevention? Biochemical Society Transactions. 33: 724-727. PMID 16042585 DOI: 10.1042/BST0330724  0.48
2005 Kashfi K, Rigas B. Molecular targets of nitric-oxide-donating aspirin in cancer Biochemical Society Transactions. 33: 701-704. PMID 16042578 DOI: 10.1042/BST0330701  0.48
2005 Kashfi K, Rigas B. Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention. Biochemical Pharmacology. 70: 969-86. PMID 15949789 DOI: 10.1016/j.bcp.2005.05.004  0.48
2005 Rigas B, Kashfi K. Cancer prevention: a new era beyond cyclooxygenase-2. The Journal of Pharmacology and Experimental Therapeutics. 314: 1-8. PMID 15805430 DOI: 10.1124/jpet.104.080564  0.48
2005 Nath N, Labaze G, Rigas B, Kashfi K. NO-donating aspirin inhibits the growth of leukemic Jurkat cells and modulates beta-catenin expression. Biochemical and Biophysical Research Communications. 326: 93-9. PMID 15567157 DOI: 10.1016/j.bbrc.2004.11.009  0.48
2005 Kashfi K, Borgo S, Williams JL, Chen J, Gao J, Glekas A, Benedini F, Del Soldato P, Rigas B. Positional isomerism markedly affects the growth inhibition of colon cancer cells by nitric oxide-donating aspirin in vitro and in vivo. The Journal of Pharmacology and Experimental Therapeutics. 312: 978-88. PMID 15528453 DOI: 10.1124/jpet.104.075994  0.48
2005 Gao J, Kashfi K, Rigas B. In vitro metabolism of nitric oxide-donating aspirin: the effect of positional isomerism. The Journal of Pharmacology and Experimental Therapeutics. 312: 989-97. PMID 15528452 DOI: 10.1124/jpet.104.076190  0.48
2004 Rigas B, Kashfi K. Nitric-oxide-donating NSAIDs as agents for cancer prevention. Trends in Molecular Medicine. 10: 324-30. PMID 15242680 DOI: 10.1016/j.molmed.2004.05.004  0.48
2004 Yeh RK, Chen J, Williams JL, Baluch M, Hundley TR, Rosenbaum RE, Kalala S, Traganos F, Benardini F, del Soldato P, Kashfi K, Rigas B. NO-donating nonsteroidal antiinflammatory drugs (NSAIDs) inhibit colon cancer cell growth more potently than traditional NSAIDs: a general pharmacological property? Biochemical Pharmacology. 67: 2197-205. PMID 15163551 DOI: 10.1016/j.bcp.2004.02.027  0.48
2004 Williams JL, Kashfi K, Ouyang N, del Soldato P, Kopelovich L, Rigas B. NO-donating aspirin inhibits intestinal carcinogenesis in Min (APC(Min/+)) mice. Biochemical and Biophysical Research Communications. 313: 784-8. PMID 14697260 DOI: 10.1016/j.bbrc.2003.12.015  0.48
2003 Williams JL, Nath N, Chen J, Hundley TR, Gao J, Kopelovich L, Kashfi K, Rigas B. Growth inhibition of human colon cancer cells by nitric oxide (NO)-donating aspirin is associated with cyclooxygenase-2 induction and beta-catenin/T-cell factor signaling, nuclear factor-kappaB, and NO synthase 2 inhibition: implications for chemoprevention. Cancer Research. 63: 7613-8. PMID 14633677  0.48
2003 Nath N, Kashfi K, Chen J, Rigas B. Nitric oxide-donating aspirin inhibits beta-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear beta-catenin-TCF association. Proceedings of the National Academy of Sciences of the United States of America. 100: 12584-9. PMID 14566053 DOI: 10.1073/pnas.2134840100  0.48
2003 Rigas B, Kalofonos H, Lebovics E, Vagenakis AG. NO-NSAIDs and cancer: Promising novel agents Digestive and Liver Disease. 35. PMID 12846441 DOI: 10.1016/S1590-8658(03)00049-5  0.48
2003 Augenlicht LH, Velcich A, Klampfer L, Huang J, Corner G, Aranes M, Laboisse C, Rigas B, Lipkin M, Yang K, Shi Q, Lesser M, Heerdt B, Arango D, Yang W, et al. Application of gene expression profiling to colon cell maturation, transformation and chemoprevention. The Journal of Nutrition. 133: 2410S-2416S. PMID 12840217  0.48
2003 Komninou D, Ayonote A, Richie JP, Rigas B. Insulin resistance and its contribution to colon carcinogenesis. Experimental Biology and Medicine (Maywood, N.J.). 228: 396-405. PMID 12671184  0.48
2003 Yang K, Fan K, Kurihara N, Shinozaki H, Rigas B, Augenlicht L, Kopelovich L, Edelmann W, Kucherlapati R, Lipkin M. Regional response leading to tumorigenesis after sulindac in small and large intestine of mice with Apc mutations. Carcinogenesis. 24: 605-11. PMID 12663524 DOI: 10.1093/carcin/24.3.605  0.48
2002 Rayyan Y, Williams J, Rigas B. The role of NSAIDs in the prevention of colon cancer. Cancer Investigation. 20: 1002-11. PMID 12449734 DOI: 10.1081/CNV-120005917  0.48
2002 Kashfi K, Ryan Y, Qiao LL, Williams JL, Chen J, Del Soldato P, Traganos F, Rigas B, Ryann Y. Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effect. The Journal of Pharmacology and Experimental Therapeutics. 303: 1273-82. PMID 12438552 DOI: 10.1124/jpet.102.042754  0.48
2002 Rigas A, Dervenis C, Giannakou N, Kozoni V, Shiff SJ, Rigas B. Selective induction of colon cancer cell apoptosis by 5-fluorouracil in humans. Cancer Investigation. 20: 657-65. PMID 12197221 DOI: 10.1081/CNV-120002491  0.48
2002 Naoumov NV, Rigas B, Donahue P, Wittkowski KM, Lebovics E, Enomoto M, Nishiguchi S. SEN viruses and treatment response in chronic hepatitis C virus [6] (multiple letters) Lancet. 359: 1779-1781. PMID 12049896  0.48
2002 Rigas B, Williams JL. NO-releasing NSAIDs and colon cancer chemoprevention: a promising novel approach (Review). International Journal of Oncology. 20: 885-90. PMID 11956579  0.48
2002 Kaza CS, Kashfi K, Rigas B. Colon cancer prevention with NO-releasing NSAIDs. Prostaglandins & Other Lipid Mediators. 67: 107-20. PMID 11936617 DOI: 10.1016/S0090-6980(02)00003-5  0.48
2002 Kaza CS, Rigas B. Rapid placement of the Sengstaken-Blakemore tube using a guidewire. Journal of Clinical Gastroenterology. 34: 282. PMID 11873114  0.48
2001 Rigas B, Hasan I, Rehman R, Donahue P, Wittkowski KM, Lebovics E. Effect on treatment outcome of coinfection with SEN viruses in patients with hepatitis C Lancet. 358: 1961-1962. PMID 11747922 DOI: 10.1016/S0140-6736(01)06968-9  0.48
2001 Rigas B, Borgo S, Elhosseiny A, Balatsos V, Manika Z, Shinya H, Kurihara N, Go M, Lipkin M. Decreased expression of DNA-dependent protein kinase, a DNA repair protein, during human colon carcinogenesis Cancer Research. 61: 8381-8384. PMID 11731412  0.48
2001 Williams JL, Borgo S, Hasan I, Castillo E, Traganos F, Rigas B. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: Implications for colon cancer chemoprevention Cancer Research. 61: 3285-3289. PMID 11309281  0.48
2001 Merritt G, Aliprandis ET, Prada F, Rigas B, Kashfi K. The retinoid fenretinide inhibits proliferation and downregulates cyclooxygenase-2 gene expression in human colon adenocarcinoma cell lines. Cancer Letters. 164: 15-23. PMID 11166911 DOI: 10.1016/S0304-3835(00)00714-X  0.48
2000 Rigas B, Shiff SJ. Is inhibition of cyclooxygenase required for the chemopreventive effect of NSAIDs in colon cancer? A model reconciling the current contradiction Medical Hypotheses. 54: 210-215. PMID 10790755 DOI: 10.1054/mehy.1999.0023  0.48
2000 Kozoni V, Tsioulias G, Shiff S, Rigas B. The effect of lithocholic acid on proliferation and apoptosis during the early stages of colon carcinogenesis: Differential effect on apoptosis in the presence of a colon carcinogen Carcinogenesis. 21: 999-1005. PMID 10783324  0.48
2000 Rigas B, Shiff SJ. Nonsteroidal anti-inflammatory drugs (NSAIDs), cyclooxygenases, and the cell cycle: Their interactions in colon cancer Advances in Experimental Medicine and Biology. 470: 119-126. PMID 10709681  0.48
2000 Rigas B, LaGuardia K, Qiao L, Bhandare PS, Caputo T, Cohenford MA. Infrared spectroscopic study of cervical smears in patients with HIV: Implications for cervical carcinogenesis Journal of Laboratory and Clinical Medicine. 135: 26-31. PMID 10638691  0.48
2000 Scotiniotis IA, Rokkas T, Furth EE, Rigas B, Shiff SJ. Altered gastric epithelial cell kinetics in Helicobacter pylori- associated intestinal metaplasia: Implications for gastric carcinogenesis International Journal of Cancer. 85: 192-200. PMID 10629077 DOI: 10.1002/(SICI)1097-0215(20000115)85:2<192::AID-IJC8>3.0.CO;2-F  0.48
1999 Santini DL, Rigas B, Shiff SJ. Role of diet and NSAIDs in the chemoprevention of colorectal cancer Journal of the Association For Academic Minority Physicians : the Official Publication of the Association For Academic Minority Physicians. 10: 68-76. PMID 10826012  0.48
1999 Shiff SJ, Rigas B. Aspirin for cancer Nature Medicine. 5: 1348-1349. PMID 10581068 DOI: 10.1038/70909  0.48
1999 Rigas B, Feretis C, Papavassiliou ED. John Lykoudis: An unappreciated discoverer of the cause and treatment of peptic ulcer disease Lancet. 354: 1634-1635. PMID 10560691 DOI: 10.1016/S0140-6736(99)06034-1  0.48
1999 Shift SJ, Rigas B. The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs) Journal of Experimental Medicine. 190: 445-450. PMID 10449515 DOI: 10.1084/jem.190.4.445  0.48
1999 Rigas B, Shiff SJ. Nonsteroidal anti-inflammatory drugs and the induction of apoptosis in colon cells: Evidence for PHS-dependent and PHS-independent mechanisms Apoptosis. 4: 373-381. DOI: 10.1023/A:1009699321946  0.48
1998 Cohenford MA, Rigas B. Cytologically normal cells from neoplastic cervical samples display extensive structural abnormalities on IR spectroscopy: Implications for tumor biology Proceedings of the National Academy of Sciences of the United States of America. 95: 15327-15332. PMID 9860968 DOI: 10.1073/pnas.95.26.15327  0.48
1998 Minoli G, Prada A, Schuman R, Murnick D, Rigas B. A simplified urea breath test for the diagnosis of Helicobacter pylori infection using the LARA System. Laser Assisted Ratio Analyzer. Journal of Clinical Gastroenterology. 26: 264-6. PMID 9649007 DOI: 10.1097/00004836-199806000-00009  0.48
1998 Qiao L, Shiff SJ, Rigas B. Sulindac sulfide alters the expression of cyclin proteins in HT-29 colon adenocarcinoma cells International Journal of Cancer. 76: 99-104. PMID 9533768 DOI: 10.1002/(SICI)1097-0215(19980330)76:1<99::AID-IJC16>3.0.CO;2-B  0.48
1998 Qiao L, Hanif R, Sphicas E, Shiff SJ, Rigas B. Effect of aspirin on induction of apoptosis in HT-29 human colon adenocarcinoma cells Biochemical Pharmacology. 55: 53-64. PMID 9413930 DOI: 10.1016/S0006-2952(97)00400-0  0.48
1997 Qiao L, Shiff SJ, Rigas B. Sulindac sulfide induces several subpopulations of colon cancer cells, defined by PCNA/Ki-67 and DNA strand breaks Biochimica Et Biophysica Acta - Molecular Cell Research. 1359: 222-232. PMID 9434128 DOI: 10.1016/S0167-4889(97)00102-X  0.48
1997 Hanif R, Qiao L, Shiff SJ, Rigas B. Curcumin, a natural plant phenolic food additive, inhibits cell proliferation and induces cell cycle changes in colon adenocarcinoma cell lines by a prostaglandin-independent pathway Journal of Laboratory and Clinical Medicine. 130: 576-584. PMID 9422331  0.48
1997 Shiff SJ, Rigas B. Nonsteroidal anti-inflammatory drugs and colorectal cancer: Evolving concepts of their chemopreventive actions Gastroenterology. 113: 1992-1998. PMID 9394740  0.48
1997 Aliprandis ET, Merritt G, Prada F, Rigas B, Kashfi K. Fenretinide inhibits phorbol ester-induced cyclooxygenase-2 expression in human colon adenocarcinoma cells. Biochemical Society Transactions. 25: 457S. PMID 9388681  0.48
1997 Cohenford MA, Godwin TA, Cahn F, Bhandare P, Caputo TA, Rigas B. Infrared spectroscopy of normal and abnormal cervical smears: evaluation by principal component analysis. Gynecologic Oncology. 66: 59-65. PMID 9234922 DOI: 10.1006/gyno.1997.4627  0.48
1997 Shiff SJ, Rigas B. Colon adenomatous polyps - Do they grow inward? Lancet. 349: 1853-1854. PMID 9217752 DOI: 10.1016/S0140-6736(05)63870-6  0.48
1997 Qiao L, Shiff SJ, Rigas B. Sulindac sulfide inhibits the proliferation of colon cancer cells: Diminished expression of the proliferation markers PCNA and Ki-67 Cancer Letters. 115: 229-234. PMID 9149129 DOI: 10.1016/S0304-3835(97)04740-X  0.48
1996 Feng Y, Papavassiliou ED, Arvind P, Tsioulias GJ, Rigas B. The effect of eicosanoids on the expression of MHC genes in cultured human colon cancer cells and mouse colonocytes in vivo Prostaglandins Leukotrienes and Essential Fatty Acids. 55: 373-378. PMID 9014214 DOI: 10.1016/S0952-3278(96)90119-2  0.48
1996 Qiao L, Koutsos M, Tsai LL, Kozoni V, Guzman J, Shiff SJ, Rigas B. Staurosporine inhibits the proliferation, alters the cell cycle distribution and induces apoptosis in HT-29 human colon adenocarcinoma cells. Cancer Letters. 107: 83-9. PMID 8913270 DOI: 10.1016/0304-3835(96)04346-7  0.48
1996 Staiano-Coico L, Carano K, Allan VM, Steiner MG, Pagan-Charry I, Bailey BB, Babaar P, Rigas B, Higgins PJ. PAI-1 gene expression is growth state-regulated in cultured human epidermal keratinocytes during progression to confluence and postwounding. Experimental Cell Research. 227: 123-34. PMID 8806459 DOI: 10.1006/excr.1996.0257  0.48
1996 Hanif R, Pittas A, Feng Y, Koutsos MI, Qiao L, Staiano-Coico L, Shiff SI, Rigas B. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway Biochemical Pharmacology. 52: 237-245. PMID 8694848 DOI: 10.1016/0006-2952(96)00181-5  0.48
1996 Rigas B. HLA and disease association: The case of gastric cancer Gastroenterology. 111: 523-526. PMID 8690220 DOI: 10.1053/gast.1996.v111.agast961110523  0.48
1996 Bortuzzo C, Hanif R, Kashfi K, Staiano-Coico L, Shiff SJ, Rigas B. The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cells Biochimica Et Biophysica Acta - Lipids and Lipid Metabolism. 1300: 240-246. PMID 8679690 DOI: 10.1016/0005-2760(96)00003-3  0.48
1996 Goldberg Y, Nassif II, Pittas A, Tsai LL, Dynlacht BD, Rigas B, Shiff SJ. The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: alterations in tumor suppressor and cell cycle-regulatory proteins. Oncogene. 12: 893-901. PMID 8632912  0.48
1996 Shiff SJ, Koutsos MI, Qiao L, Rigas B. Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: Effects on cell cycle and apoptosis Experimental Cell Research. 222: 179-188. PMID 8549662 DOI: 10.1006/excr.1996.0023  0.48
1996 Rigas B. Aspirin and aspirin-like drugs induce HLA-DR expression in HT29 colon cancer cells International Journal of Oncology. 8: 1207-1211.  0.48
1996 Içashfi K, Shiff SI, Rigas B, Hirsch T. Evidence that human epithelial cells express leukotriene receptors Faseb Journal. 10.  0.48
1995 Rigas B. Prostaglandins and the pathophysiology of esophagitis Journal of Clinical Gastroenterology. 21: 266-267. PMID 8583096  0.48
1995 Arvind P, Papavassiliou ED, Tsioulias GJ, Qiao L, Lovelace CIP, Duceman B, Rigas B. Prostaglandin E2 down-regulates the expression of HLA-DR antigen in human colon adenocarcinoma cell lines Biochemistry. 34: 5604-5609. PMID 7727422  0.48
1995 Koutsos MI, Shiff SJ, Rigas B. Can Nonsteroidal Anti-Inflammatory Drugs Be Recommended to Prevent Colon Cancer in High Risk Elderly Patients? Drugs &Amp; Aging. 6: 421-425. PMID 7663061 DOI: 10.2165/00002512-199506060-00001  0.48
1995 Shiff SJ, Qiao L, Tsai LL, Rigas B. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. The Journal of Clinical Investigation. 96: 491-503. PMID 7615821 DOI: 10.1172/JCI118060  0.48
1995 Teintze M, Arzimanoglou II, Lovelace CIP, Xu ZJ, Rigas B. RecA-assisted rapid enrichment of specific clones from model DNA libraries Biochemical and Biophysical Research Communications. 211: 804-811. PMID 7598709 DOI: 10.1006/bbrc.1995.1883  0.48
1995 Qiao L, Kozoni V, Tsioulias GJ, Koutsos MI, Hanif R, Shiff SJ, Rigas B. Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo Biochimica Et Biophysica Acta (Bba)/Lipids and Lipid Metabolism. 1258: 215-223. PMID 7548186 DOI: 10.1016/0005-2760(95)00100-Q  0.48
1995 Schuman RW, Rigas B. Bipolar electrocautery as an alternative to Nd:YAG laser for the treatment of the watermelon stomach. Gastrointestinal Endoscopy. 42: 277-8. PMID 7498702 DOI: 10.1016/S0016-5107(95)70114-1  0.48
1994 Arvind P, Papavassiliou ED, Tsioulias GJ, Duceman BW, Lovelace CIP, Geng W, Staiano-Coico L, Rigas B. Lithocholic acid inhibits the expression of HLA class I genes in colon adenocarcinoma cells. differential effect on HLA-A, -B and -C LOCI Molecular Immunology. 31: 607-614. PMID 8196671 DOI: 10.1016/0161-5890(94)90168-6  0.48
1994 Sun Y, Rigas B. Detection of biotinylated nucleic acids directly on agarose gels Biotechniques. 16: 782-784. PMID 8068322  0.48
1994 Papavassiliou ED, Arvind P, Tsioulias GJ, Qiao L, Goldin E, Staiano-Coico L, Rigas B. The effect of ethanol on the expression of HLA class I genes in human colon adenocarcinoma cell lines Cancer Letters. 81: 33-38. PMID 8019985 DOI: 10.1016/0304-3835(94)90161-9  0.48
1994 Pochapin MB, Fine SN, Eisorfer RM, Rigas B. Fecal occult blood testing in hospitalized patients Journal of Clinical Gastroenterology. 19: 274-277. PMID 7876504  0.48
1994 Rigas B, Tsioulias GJ, Allan C, Wali RK, Brasitus TA. The effect of bile acids and piroxicam on MHC antigen expression in rat colonocytes during colon cancer development Immunology. 83: 319-323. PMID 7835954  0.48
1993 Tsioulias GJ, Triadafilopoulos G, Goldin E, Papavassiliou ED, Rizos S, Bassioukas P, Rigas B. Expression of HLA Class I Antigens in Sporadic Adenomas and Histologically Normal Mucosa of the Colon Cancer Research. 53: 2374-2378. PMID 8485724  0.48
1993 Rigas A, Rigas B, Glassman M, Yen YY, Lan SJ, Petridou E, Hsieh CC, Trichopoulos D. Breast-feeding and maternal smoking in the etiology of Crohn's disease and ulcerative colitis in childhood Annals of Epidemiology. 3: 387-392. PMID 8275215 DOI: 10.1016/1047-2797(93)90066-D  0.48
1993 Rigas B, Goldman IS, Levine L. Altered eicosanoid levels in human colon cancer The Journal of Laboratory and Clinical Medicine. 122: 518-523. PMID 8228569  0.48
1993 Rigas B. Molecular gastroenterology—Implications for medical practice Journal of Clinical Gastroenterology. 17: 184-186. PMID 8228075  0.48
1992 Rigas B, Wong PTT. Human Colon Adenocarcinoma Cell Lines Display Infrared Spectroscopic Features of Malignant Colon Tissues Cancer Research. 52: 84-88. PMID 1727389  0.48
1992 Tsioulias G, Godwin TA, Goldstein MF, McDougall CJ, Sing-Shang N, DeCosse JJ, Rigas B. Loss of Colonic HLA Antigens in Familial Adenomatous Polyposis Cancer Research. 52: 3449-3452. PMID 1317751  0.48
1991 Wong PT, Wong RK, Caputo TA, Godwin TA, Rigas B. Infrared spectroscopy of exfoliated human cervical cells: evidence of extensive structural changes during carcinogenesis. Proceedings of the National Academy of Sciences of the United States of America. 88: 10988-92. PMID 1763013  0.48
1991 Minoli G, Imperiale G, Spinzi GC, Terruzzi V, Rigas B. Circadian periodicity and other clinical features of biliary pain Journal of Clinical Gastroenterology. 13: 546-548. PMID 1744391  0.48
1990 Rigas B, Torosis J, McDougall CJ, Vener KJ, Spiro HM. The circadian rhythm of biliary colic Journal of Clinical Gastroenterology. 12: 409-414. PMID 2398248  0.48
1990 Staiano-Coico L, Khandke L, Krane JF, Sharif S, Gottlieb AB, Krueger JG, Heim L, Rigas B, Higgins PJ. TGF-α and TGF-β expression during sodium-N-butyrate-induced differentiation of human keratinocytes: Evidence for subpopulation-specific up-regulation of TGF-β mRNA in suprabasal cells Experimental Cell Research. 191: 286-291. PMID 2257881 DOI: 10.1016/0014-4827(90)90016-4  0.48
1990 Rigas B, Morgello S, Goldman IS, Wong PT. Human colorectal cancers display abnormal Fourier-transform infrared spectra. Proceedings of the National Academy of Sciences of the United States of America. 87: 8140-4. PMID 2236027  0.48
1990 Rigas B. Editorial: Oncogenes and suppressor genes: Their involvement in colon cancer Journal of Clinical Gastroenterology. 12: 494-499. PMID 2229991  0.48
1990 Ergun GA, Rigas B. Circadian periodicity of the time of onset of acute lower gastrointestinal bleeding Progress in Clinical and Biological Research. 341: 221-228. PMID 2217314  0.48
1990 McDougall CJ, Ngoi SS, Godwin T, Felix J, DeCosse JJ, Rigas B, Goldman IS. Reduced Expression of HLA Class I and II Antigens in Colon Cancer Cancer Research. 50: 8023-8027. PMID 2123744  0.48
1989 Rigas B, Korenberg JR, Merrill WW, Levine L. Prostaglandins E2 and E2 alpha are elevated in saliva of cystic fibrosis patients. The American Journal of Gastroenterology. 84: 1408-12. PMID 2816873  0.48
1989 Rigas B. The evolving spectrum of amiodarone hepatotoxicity Hepatology. 10: 116-117. PMID 2737596  0.48
1989 van Vunakis H, Tashkin DP, Rigas B, Simmons M, Gjika HB, Clark VA. Relative sensitivity and specificity of salivary and serum cotinine in identifying tobacco-smoking status of self-reported nonsmokers and smokers of tobacco and/or marijuana. Archives of Environmental Health. 44: 53-8. PMID 2644896 DOI: 10.1080/00039896.1989.9935873  0.48
1986 Rigas B, Rosenfeld LE, Barwick KW, Enriquez R, Helzberg J, Batsford WP, Josephson ME, Riely CA. Amiodarone hepatotoxicity. A clinicopathologic study of five patients Annals of Internal Medicine. 104: 348-351. PMID 3946978  0.48
1986 Rigas B. Eicosanoids and the gastrointestinal tract: Promising but no verdict yet American Journal of Gastroenterology. 81: 218-221. PMID 3513546  0.48
1986 Lawrence SK, Srivastava R, Rigas B, Chorney MJ, Gillespie GA, Smith CL, Cantor CR, Collins FS, Weissman SM. Molecular approaches to the characterization of megabase regions of DNA: Applications to the human major histocompatibility complex Cold Spring Harbor Symposia On Quantitative Biology. 51: 123-130. PMID 3472708  0.48
1986 Rigas B, Welcher AA, Ward DC, Weissman SM. Rapid plasmid library screening using RecA-coated biotinylated probes. Proceedings of the National Academy of Sciences of the United States of America. 83: 9591-5. PMID 3467328  0.48
1983 Rigas B, Levine L. Concentrations of arachidonic-acid metabolites in human mixed saliva are independent of flow rate Archives of Oral Biology. 28: 1135-1137. PMID 6582819 DOI: 10.1016/0003-9969(83)90171-1  0.48
1983 Rigas B, Levine L. Human salivary eicosanoids: Circadian variation Biochemical and Biophysical Research Communications. 115: 201-205. PMID 6351860 DOI: 10.1016/0006-291X(83)90989-0  0.48
1983 Rigas B, Lewis RA, Ausien KF, Corey EJ, Levine L. Identification and quantitation of arachidonic-acid metabolic products in rabbit, rat and human saliva Archives of Oral Biology. 28: 1031-1035. PMID 6318707 DOI: 10.1016/0003-9969(83)90058-4  0.48
Show low-probability matches.